Lifestyle
Archived — This article has been archived. The information may be outdated.
Bengaluru doctors welcome India's first dengue vaccine
Deccan Herald··25 Jul
Bengaluru doctors described approval of India's first dengue vaccine Qdenga as a significant public health advance on July 25. Karnataka weekly dengue cases rose from 93 in early July to 127, dipped to 106, then surged to 229 in the third week, health department data showed. CDSCO cleared the Takeda vaccine for ages four to 60.
Prism
What It Means For You
- Families in dengue endemic states may soon access Qdenga privately.
- Two dose schedules require planning three months apart.
- Vaccination may complement existing mosquito control measures.
What's Happening
- Bengaluru doctors welcomed Qdenga approval on July 25.
- Karnataka weekly dengue cases hit 229 in mid July.
- CDSCO cleared the vaccine for ages four to 60.
Dengue Burden Context
- India reported over 121,000 dengue cases nationwide in 2025.
- Qdenga is imported by Takeda Biopharmaceuticals India initially.
- Health ministry said approval supports vector borne disease control efforts.
all-news
